Jun Yamamoto, Kentaro Miyake, Qinghong Han, Yuying Tan, Sachiko Inubushi, Norihiko Sugisawa, Takashi Higuchi, Yoshihiko Tashiro, Hiroto Nishino, Yuki Homma, et al. Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model. Cancer letters. 2020
Mickhael Bang Langit, Shinji Miwa, Norio Yamamoto, Katsuhiro Hayashi, Akihiko Takeuchi, Kentaro Igarashi, Kaoru Tada, Takashi Higuchi, Hirotaka Yonezawa, Sei Morinaga, et al. Risk Factors for Postoperative Deep Infection After Malignant Bone Tumor Surgery of the Extremities. Anticancer research. 2020. 40. 6. 3551-3557
Jun Yamamoto, Takuya Murata, Norihiko Sugisawa, Takashi Higuchi, Yoshihiko Tashiro, Hiroto Nishino, Sachiko Inubushi, Y U Sun, Hyein Lim, Kentaro Miyake, et al. Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model. Anticancer research. 2020. 40. 5. 2475-2479
Jun Yamamoto, Takuya Murata, Yoshihiko Tashiro, Takashi Higuchi, Norihiko Sugisawa, Hiroto Nishino, Sachiko Inubushi, Y U Sun, Hyein Lim, Kentaro Miyake, et al. A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to Olaparib. Anticancer research. 2020. 40. 5. 2509-2514
Kentaro Igarashi, Kei Kawaguchi, Ming Zhao, Qinghong Han, Yuying Tan, Tasuku Kiyuna, Kentaro Miyake, Takashi Higuchi, Scott D Nelson, Sarah M Dry, et al. Recombinant Methioninase Combined With Tumor-targeting Salmonella typhimurium A1-R Induced Regression in a PDOX Mouse Model of Doxorubicin-resistant Dedifferentiated Liposarcoma. Anticancer research. 2020. 40. 5. 2515-2523
Nab-paclitaxel combined with gemcitabine inhibits undifferentiated sarcoma growth in the patient-derived orthotopic xenograft (PDOX) model: promising a novel therapeutic strategy for sarcoma
(2019 Annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) 2019)
Efficacy of olaratumab in combination with different standard chemotherapeutic regimens in the treatment of undifferentiated soft tissue sarcoma: in vivo study using patient-derived orthotopic xenograft (PDOX) mouse model
(2019 Annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) 2019)
Anti-proliferative effect of a non-steroidal anti-inflammatory drug zaltoprofen on chondrosarcoma growth via activating PPARγ (peroxisome proliferator-activated receptor gamma) and p21
(2019 Annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) 2019)
Combination of gemcitabine and nab-paclitaxel inhibits undifferentiated sarcoma growth in patient-derived orthotopic xenograft (PDOX) model promising a new therapeutic strategy
(39th Société Internationale de Chirurgie Orthopédique et de Traumatologie (SICOT) Orthopaedic World Congress 2018)
Calcium phosphate cement in the surgical management of benign bone tumors: Mid- to long-term radiographic and clinical outcomes
(39th Société Internationale de Chirurgie Orthopédique et de Traumatologie (SICOT) Orthopaedic World Congress 2018)
